Doximity Inc (DOCS)vsEvolent Health Inc (EVH)
DOCS
Doximity Inc
$33.63
-1.81%
HEALTHCARE · Cap: $6.10B
EVH
Evolent Health Inc
$4.25
-1.85%
HEALTHCARE · Cap: $550.60M
Smart Verdict
WallStSmart Research — data-driven comparison
Evolent Health Inc generates 220% more annual revenue ($2.10B vs $655.57M). DOCS leads profitability with a 25.5% profit margin vs -24.1%. DOCS appears more attractively valued with a PEG of 0.59. DOCS earns a higher WallStSmart Score of 57/100 (C).
DOCS
Buy57
out of 100
Grade: C
EVH
Buy52
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+49.3%
Fair Value
$51.22
Current Price
$33.63
$17.59 discount
Intrinsic value data unavailable for EVH.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Every $100 of equity generates 21 in profit
Keeps 26 of every $100 in revenue as profit
Growing faster than its price suggests
Strong operational efficiency at 21.5%
Reasonable price relative to book value
Revenue surging 46.9% year-over-year
Areas to Watch
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 51.9%
Expensive relative to growth rate
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -131.8% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : DOCS
The strongest argument for DOCS centers on Debt/Equity, Altman Z-Score, Return on Equity. Profitability is solid with margins at 25.5% and operating margin at 21.5%. PEG of 0.59 suggests the stock is reasonably priced for its growth.
Bull Case : EVH
The strongest argument for EVH centers on Price/Book, Revenue Growth. Revenue growth of 46.9% demonstrates continued momentum.
Bear Case : DOCS
The primary concerns for DOCS are Piotroski F-Score, P/E Ratio, EPS Growth. A P/E of 40.3x leaves little room for execution misses.
Bear Case : EVH
The primary concerns for EVH are PEG Ratio, EPS Growth, Market Cap. Debt-to-equity of 2.53 is elevated, increasing financial risk.
Key Dynamics to Monitor
DOCS profiles as a mature stock while EVH is a hypergrowth play — different risk/reward profiles.
DOCS carries more volatility with a beta of 1.22 — expect wider price swings.
EVH is growing revenue faster at 46.9% — sustainability is the question.
DOCS generates stronger free cash flow (42M), providing more financial flexibility.
Bottom Line
DOCS scores higher overall (57/100 vs 52/100), backed by strong 25.5% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Doximity Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Doximity, Inc. (Ticker: DOCS) is a U.S. healthcare technology company that operates a digital platform tailored for medical professionals. The company’s cloud-based network provides secure communication and collaboration tools, telemedicine services, clinical workflow solutions, and access to medical news, research, and career-management features for physicians, nurse practitioners, physician assistants, and other clinicians. Headquartered in San Francisco, California, Doximity’s Class A common stock trades on the New York Stock Exchange under the ticker DOCS.
Evolent Health Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the United States. The company is headquartered in Arlington, Virginia.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?